Advertisement

Cellular and molecular mechanisms of radioresistance

Chapter
Part of the Cancer Treatment and Research book series (CTAR, volume 74)

Abstract

Outstanding work on the cellular and molecular aspects of radioresistance has been published in the past 10 years [1,2]. The work presented herein does not attempt to be comprehensive but is a review of the work of our laboratory as it pertains to aspects of radioresistance with potential applicability to chemotherapy/cytokine radiotherapy interactions.

Keywords

Human Squamous Cell Carcinoma Neck Cancer Cell Line Radiation Survival Human Laryngeal Carcinoma Human Diploid Fibroblast Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Peters LJ, Brock WA, Johnson T, Meyn RE, Tofilon PJ, Milas L. Potential methods for predicting tumor radiocurability. Int J Radiat Oncol Biol Phys 12:459–467, 1986.PubMedCrossRefGoogle Scholar
  2. 2.
    Brock WA, Baker FL, Wike JL, Sivon SL, Peters LJ. Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys 18:1283–1286, 1990.PubMedCrossRefGoogle Scholar
  3. 3.
    Weichselbaum RR, Dahlberg W, Beckett MA, Karrison T, Miller D, Clark J, Ervin TJ. Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head and neck cancer patients. Proc Natl Acad Sci USA 83:2684–2688, 1986.PubMedCrossRefGoogle Scholar
  4. 4.
    Weichselbaum RR, Beckett MA, Vijayakumar S, Simon MA, Awan AA, Nachman J, Panje WR, Goldman ME, Tybor AG, Moran WJ, Vokes EE, Ahmed-Swan S, Farhangi, E. Radiobiological characterization of head and neck sarcoma cells derived from patients prior to radiotherapy. Int J Radiat Oncol Biol Phys 19:313–319, 1990.PubMedCrossRefGoogle Scholar
  5. 5.
    Weichselbaum RR, Beckett MA, Schwartz JL, Dritschilo A. Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. Int J Radiat Oncol Biol Phys 15:575–579, 1988.PubMedCrossRefGoogle Scholar
  6. 6.
    Weichselbaum RR, Nove J, Little JB. Radiation response of human tumor cells in vitro. In: RH Withers, R Meyn, eds. Radiation Biology and Cancer Research. New York: Raven Press, 1980, pp 345–351.Google Scholar
  7. 7.
    Elkind MM, Sutton H. X-ray damage and recovery in mammalian cells in culture. Nature 184:1293–1295, 1969.CrossRefGoogle Scholar
  8. 8.
    Elkind MM. Fractionated dose radiotherapy and its relationship to survival curve shapes. Cancer Treat Rev 3:2–15, 1976.CrossRefGoogle Scholar
  9. 9.
    Nilsson S, Carlsson J, Larsson B. Survival of irradiated glia and glioma cells studied with a new cloning technique. Int J Radiat Biol 37:267–279, 1980.CrossRefGoogle Scholar
  10. 10.
    Weichselbaum RR, Dahlberg W, Little JB. Inherently radioresistant cells exist in some human tumors. Proc Natl Acad Sci USA 87:4732–4735, 1985.CrossRefGoogle Scholar
  11. 11.
    Weichselbaum RR, Nove J, Little JB. X-ray sensitivity of 53 human diploid fibroblast cell strains from patients with characterized genetic disorders. Cancer Res 40:920–925, 1980.PubMedGoogle Scholar
  12. 12.
    Withers HR. Biological basis of radiation therapy. In: CA Peres, LW Brady, eds. Principles and Practice of Radiation Oncology. Philadelphia: JB Lippincott, 1987, pp 67–98.Google Scholar
  13. 13.
    Phillips RA, Tolmach LJ. Repair of potentially lethal damage in x-irradiated HeLa cells. Radiat Res 29:413–432, 1966.PubMedCrossRefGoogle Scholar
  14. 14.
    Weichselbaum RR, Nove J, Little JB. Deficient recovery from potentially lethal radiation damage in ataxia telangiectasia and xeroderma pigmentosum. Nature 27:261–262, 1978.CrossRefGoogle Scholar
  15. 15.
    Weichselbaum RR, Schmit A, Little JB. Cellular repair factors influencing radiocurability of human malignant tumors. Br J Cancer 45:10–16, 1982.PubMedCrossRefGoogle Scholar
  16. 16.
    Weichselbaum RR, Little JB. The differential response of human tumors to fractionated radiation may be due to a post-irradiation repair process. Br J Cancer 46:532–537, 1982.PubMedCrossRefGoogle Scholar
  17. 17.
    Weichselbaum RR, Beckett MA. The maximum recovery potential of human tumor cells may predict clinical outcome in radiotherapy. Int J Radiat Oncol Biol Phys 13:709–713, 1987.PubMedCrossRefGoogle Scholar
  18. 18.
    Fu KK, Phillips TL. Biologic rationale of combined radiotherapy and chemotherapy. Hemotol/Oncol Clin North Am 5:737–751, 1991.Google Scholar
  19. 19.
    Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 8:911–934, 1990.PubMedGoogle Scholar
  20. 20.
    Quiet C, Weichselbaum RR, Gradina D. Variation in radiation sensitivity during the cell cycle to two human squamous cell carcinomas. Int J Radiat Oncol Biol Phys 20:733–738, 1991.PubMedCrossRefGoogle Scholar
  21. 21.
    Vokes EE, Panje WR, Schilsky RL, Mick R, Awan AM, Moran WJ, Goldman MD, Tybor AG, Weichselbaum RR. Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: A phase I-II study. J Clin Oncol 7:761–768, 1989.PubMedGoogle Scholar
  22. 22.
    Haraf DJ, Vokes EE, Panje WR, Weichselbaum RR. Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer. Am J Clin Oncol 14:419–426, 1991.PubMedCrossRefGoogle Scholar
  23. 23.
    Weppelmann B, Wheeler RA, Peters GE, Kim RY, Spencer SA, Meredith RF, Salter MM. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea and reirradiation. Int J Radiat Oncol Biol Phys 22:1051–1056, 1992.PubMedCrossRefGoogle Scholar
  24. 24.
    Guillot T, Wibault P, Cvitkovit E, Luboinski E, Tellez B, Eschwege F, Schwaab G, Armand JP. Treatment of ‘favorable’ recurrent (REC) head and neck squamous cell cancer (H+NSCC) with 5 days on/9 days simultaneous chemoradiotherapy (CH/RT) Vokes-Weichselbaum (VW) protocol (abstract #684). Proc Am Soc Clin Oncol 9:177, 1990.Google Scholar
  25. 25.
    Vokes EE, Beckett M, Karrison T, Weichselbaum RR. The interaction of 5-fluorouracil, hydroxyurea and radiation in two human head and neck cancer cell lines. Oncology 49:454–460, 1992.PubMedCrossRefGoogle Scholar
  26. 26.
    Bohr VA, Evans MK, Fornace AJ. DNA repair and its pathogenetic implications. Lab Invest 61:143–161, 1989.PubMedGoogle Scholar
  27. 27.
    Thompson LH, Brookman KW, Jones NJ, Allen SA, Carrano AV. Molecular cloning of the human XRCC-1 gene, which corrects defective DNA strand break repair and sister chromatid exchange. Mol Cell Biol 10:6160–6171, 1990.PubMedGoogle Scholar
  28. 28.
    Dunphy EJ, Beckett MA, Thompson LH, Weichselbaum RR. Expression of the polymorphic human DNA repair gene XRCC-1 does not correlate with radiosensitivity in human head and neck tumor cell lines. Radiat Res 130:166–170, 1992.PubMedCrossRefGoogle Scholar
  29. 29.
    Weinert TA, Hartwell LH. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241:317–322, 1988.PubMedCrossRefGoogle Scholar
  30. 30.
    Mitchell JB, Cook JA, DeGraff W, Glatstein E, Russo A. Glutathione modulation in cancer treatment: Will it work? Int J Radiat Oncol Biol Phys 16:1289–1295, 1989.PubMedCrossRefGoogle Scholar
  31. 31.
    Fitzgerald TJ, Daugherty C, Kase K, Rothstein LA, McKenna M, Greenberger JS. Activated human n-ras oncogene enhances x-irradiation repair of mammalian cells in vitro less efficiently at low dose rates. Am J Clin Oncol 8:517–522, 1985.PubMedCrossRefGoogle Scholar
  32. 32.
    Sklar MD. The ras-oncogenes increase the intrinsic resistance of NIH/3T3 cells to ionizing radiation. Science 239:645–657, 1989.CrossRefGoogle Scholar
  33. 33.
    Kasid U, Pfeifer A, Weichselbaum RR, Dritschilo A, Mark GE. The raf-oncogene is associated with the radiation-resistant human laryngeal cancer. Science 237:1039–1041, 1987.PubMedCrossRefGoogle Scholar
  34. 34.
    Kasid U, Pfeifer A, Brennan T, Beckett MA, Weichselbaum RR, Dritschilo A, Mark GE. Effect of anti-sense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous cell carcinoma. Science 243:1354–1356, 1989.PubMedCrossRefGoogle Scholar
  35. 35.
    Pirollo KF, Garner R, Yuan SY, Li L, Blather WA, Chang EH. Raf involvement in the simultaneous genetic transfer of the radioresistant and transforming phenotypes. Int J Radiat Biol 55:783–796, 1989.PubMedCrossRefGoogle Scholar
  36. 36.
    Horiguchi J, Spriggs D, Imamura K, Stone R, Leubbers R, Kufe D. Role of arachidonic acid metabolism in transcriptional induction of tumor necrosis factor gene expression by phorbol ester. Mol Cell Biol 9:252–258, 1989.PubMedGoogle Scholar
  37. 37.
    Rozengurt E, Rodriguez-Pena A, Coombs M, Sinnett-Smith J. Diacylglycerol stimulates DNA synthesis and cell division in mouse 3T3 cells: Role of Ca+ 2-sensitive phospholipid-dependent protein kinase. Proc Natl Acad Sci USA 81:5748–5752, 1984.PubMedCrossRefGoogle Scholar
  38. 38.
    Hallahan D, Virudachalam S, Sherman ML, Huberman E, Kufe DW, Weichselbaum RR. Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation. Cancer Res 51:4565–4569, 1991.PubMedGoogle Scholar
  39. 39.
    Hallahan DE, Sukhatme VP, Sherman ML, Virudachalam S, Kufe D, Weichselbaum RR. Protein kinase C mediates x-ray inducibility of nuclear signal transducers, egr-1 and c-jun. Proc Natl Acad Sci USA 88:2152–2160, 1991.Google Scholar
  40. 40.
    Hallahan DE, Virudachalam S, Schwartz JL, Panje N, Mustafi R, Weichselbaum RR. Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation. Radiat Res 129:345–350, 1992.PubMedCrossRefGoogle Scholar
  41. 41.
    Witte L, Fuks Z, Haimovitz-Friedman A, Vlodavsky I, Goodman DS, Eldor A. Effects of radiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. Cancer Res 49:5066–5072, 1989.PubMedGoogle Scholar
  42. 42.
    Haimovitz-Friedman A, Vlodavsky I, Chaudhuri A, Witte L, Fuks Z. Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res 51:2552–2558, 1991.PubMedGoogle Scholar
  43. 43.
    Hallahan DE, Spriggs DR, Beckett MA, Kufe DW, Weichselbaum RR. Increased tumor necrosis factor-alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci USA 86:10104–10107, 1989.PubMedCrossRefGoogle Scholar
  44. 44.
    Sherman ML, Datta R, Hallahan DE, Weichselbaum RR, Kufe DW. Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes. J Clin Invest 87:1794–1797, 1991.PubMedCrossRefGoogle Scholar
  45. 45.
    Hallahan DE, Beckett MA, Kufe D, Weichselbaum RR. Interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines. Int J Radiat Oncol Biol Phys 19:69–74, 1990.PubMedCrossRefGoogle Scholar
  46. 46.
    Neta R, Oppenheim JJ, Schreiber RD, Chizzonite R, Ledney GD, Mac Vittie T. Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radioresistance. J Exp Med 173:1177–1182, 1991.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

There are no affiliations available

Personalised recommendations

Cite chapter

Buy options